Virtual Data Room Resources

Practical Application of Artificial Intelligence in Drug Discovery and Development

In this whitepaper, learn what is artificial intelligence and how is it being applied to drug discovery, and much more.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Jan 12, 2021 Whitepapers

The Seven Habits of Highly Effective Data Rooms

In this whitepaper, you will learn the seven "habits" of highly effective data rooms to ensure your selection facilitates the due diligence process rather than impede it.

Best Practices & Trends Energy Finance Legal Life Sciences Other Industries Real Estate Virtual Data Room Whitepapers

Jan 12, 2021 Whitepapers

Essential Steps to Successful Biopharma Partnering

This whitepaper provides a strategic perspective coupled with actionable tips to help guide you through the essential steps that will help maximize your chance of achieving success in biopharma partnering.

BioPharma Licensing & Partnering Life Sciences Whitepapers

Jan 12, 2021 Whitepapers

Valuation of Your Early Drug Candidate

In this whitepaper, author Linda Pullan reviews the different techniques, key variables, and characteristics of what makes a drug candidate more valuable to a partner.

Life Sciences Series Valuation Whitepapers

Jan 12, 2021 Whitepapers

Successful Biotech Licensing Negotiations

In this whitepaper, Linda Pullan provides licensing negotiations insights from a biotech business development perspective.

BioPharma Life Sciences Other Topics Whitepapers

Jan 12, 2021 Whitepapers

A Medical Device Manufacturer's Guide to Selecting Suppliers

This white paper covers when to consider using suppliers, key differences between standard / OTS and custom part suppliers, tools and methods for managing suppliers, and when and how to transition between suppliers and internal resources.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Jan 12, 2021 Whitepapers

Getting Ready for a Biopharma Partnering Deal

This whitepaper provides actionable advice for Biotech business development leaders on how to get ready for a partnering deal.

Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers

Jan 12, 2021 Whitepapers

How to Apply the Golden Rule of Research to your Trial Master File

This whitepaper evaluates the regulations that support GDP, best practices on how document contributors can apply the golden rule of research to their TMF, how to avoid writing too many and unnecessary Note-to-Files (NTFs), and tips on becoming inspection ready and staying that way.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Jan 12, 2021 Whitepapers

Must-Know Finance Concepts for Life Sciences Valuations - Part II

This whitepaper discusses which asset valuation methodology is most used by big pharma to evaluate possible partners or acquisitions and an explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital, and present value.

Best Practices & Trends BioPharma Life Sciences Valuation Whitepapers

Jan 12, 2021 Whitepapers

Selling Your Healthcare or Life Sciences Company

This whitepaper gives medical groups, life sciences, and healthcare companies in the lower middle market an understanding of financing and M&A alternatives available, the role of financial buyers, key issues around selling equity in your business, and the typical financing and M&A process.

BioPharma Life Sciences Other Industries Other Topics Whitepapers

Jan 12, 2021 Whitepapers

M&A Negotiations

This whitepaper shares the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered.

Best Practices & Trends Life Sciences Mergers & Acquisitions Negotiation Whitepapers

Jan 12, 2021 Whitepapers

Pullan's Pieces - A Business Development View of the Oncology Landscape

In this whitepaper, biopharma partnering expert and Life Sciences consultant, Linda Pullan, PhD, explores the current oncology landscape and offers insightful perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.

Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers

Jan 12, 2021 Whitepapers

SHAREVAULT RESOURCES